These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1312208)

  • 1. Dopaminergic regulation of cholecystokinin mRNA content in rat striatum.
    Ding XZ; Mocchetti I
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):77-83. PubMed ID: 1312208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis.
    Ding XZ; Mocchetti I
    J Pharmacol Exp Ther; 1992 Oct; 263(1):368-73. PubMed ID: 1403798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment.
    Hu XT; Wang RY
    Brain Res; 1989 May; 486(2):325-33. PubMed ID: 2786442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
    Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
    Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat.
    Angulo JA; Coirini H; Ledoux M; Schumacher M
    Brain Res Mol Brain Res; 1991 Sep; 11(2):161-6. PubMed ID: 1661813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
    Diana M; Young SJ; Groves PM
    Neuroscience; 1991; 42(2):441-9. PubMed ID: 1680226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells.
    Twery MJ; Thompson LA; Walters JR
    Synapse; 1994 Sep; 18(1):67-78. PubMed ID: 7825125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
    Neal BS; Joyce JN
    Brain Res Dev Brain Res; 1991 Jun; 60(2):105-13. PubMed ID: 1832593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptors expressed in the Xenopus oocytes injected with bovine striatal mRNA.
    Sakai Y; Sekiguchi M; Okamoto K; Kuwano R; Takahashi Y
    Brain Res Mol Brain Res; 1990 Feb; 7(2):183-7. PubMed ID: 2160046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Mar; 13(1-2):35-41. PubMed ID: 1315917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.